Commissioners approved a tax exemption of 100% for the next five years for Roy’s Restaurant in Steinhatchee at Monday night’s ...
Direxion is looking to capitalize on growing investor enthusiasm around AI memory stocks by filing with the U.S. Securities ...
Women in Toys, Licensing, and Entertainment (WiT) has officially announced the finalists for this year’s Wonder Women Awards.
Anonymous-linked Canadian hacker jailed, researcher drops zero-days in open source projects, Venezuelans sentenced in the US over ATM jackpotting. SecurityWeek’s cybersecurity news weekly roundup ...
Researchers have found a never-before-seen piece of macOS malware that combines a series of clever tradecraft to infect Macs ...
The U.S. Securities and Exchange Commission sought ‌public comment on Tuesday for regulating "novel" exchange-traded funds, a fast-growing category of products that employ leverage or options or are ...
A new macOS ClickFix campaign is using Terminal commands to silently download, mount, and launch info-stealing malware from ...
FedEx has spent the last three years rebuilding its business. Investors now want to know if the payoff is finally arriving. FedEx reports is fiscal 2026 fourth quarter earnings on the evening of June ...
COLUMBUS, Ohio — People across northeast Ohio are now receiving AI phone calls to help them prep for surgery and navigate care after they leave the hospital. It’s all part of the “transformation” plan ...
A single-atom platinum catalyst lights ammonia at 200 °C and keeps it burning steadily at 1,100 °C with low NO x, generating high-grade, carbon-free heat for steel, cement and chemicals. Ammonia is a ...
With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...
Rare-disease specialist Catalyst Pharmaceuticals is set to be acquired by healthcare group Angelini Pharma in a $4.1 billion deal. Angelini will pay $31.50 for each of Nasdaq-listed Catalyst’s ...